華陽國際(002949.SZ):聯合體3.09億元競得龍華民治一宗工業地
格隆匯12月11日丨華陽國際(002949.SZ)公佈,公司第二屆董事會第八次會議審議通過了《關於公司擬參與聯合競買龍華區民治街道A810-0043地塊的議案》,同意公司使用約1.35億元人民幣的自有或自籌資金與其他三家企業(“各聯合競拍方”)聯合競拍龍華區民治街道A810-0043地塊。
2019年12月11日,各聯合競拍方按照法定程序通過深圳市土地房產交易中心公開掛牌交易,以人民幣3.09億元競得龍華區民治街道A810-0043宗地的土地使用權,並簽署了成交確認書,預計公司出資額為約1.35億元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.